Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Regeneration
Regeneration in horses refers to the biological processes by which horses repair or replace damaged tissues and organs. These processes involve a range of cellular activities, including cell proliferation, differentiation, and tissue remodeling. Regeneration can occur in various tissues, such as skin, muscle, and bone, and is influenced by factors like age, health status, and the extent of injury. In equine research, understanding the mechanisms and limitations of regeneration is important for developing therapeutic strategies to enhance recovery from injuries. This page compiles peer-reviewed research studies and scholarly articles that investigate the cellular and molecular mechanisms underlying regenerative processes in horses, as well as their implications for equine health and rehabilitation.
Periodontal regeneration capacity of equine particulate bone in canine alveolar bone defects. This study was performed to evaluate the periodontal wound healing effect of particulate equine bone mineral on canine alveolar bone defects. Methods: Twelve adult male beagle dogs were used as study subjects. The mandibular second and fourth premolars were extracted prior to the experimental surgery, and the extraction sites were allowed to heal for 8 weeks. After periodontal probing, two-walled defects were created at the mesial and distal sides of the mandibular third premolars bilaterally, and the defects were filled with equine particulate bone with collagen membrane or bovine particulate...
Tissue engineering in wound repair: the three “R”s–repair, replace, regenerate. Horses are predisposed to traumatic wounds that can be labor intensive and expensive to manage. Skin has a considerable potential for efficient and functional repair however, while cutaneous repair is a regenerative process in the fetus, this capability declines in late gestation as inflammation and scarring alter the outcome of healing. The historical gold standard for replacement of lost skin is the autologous skin graft. However, the horse's lack of redundant donor skin limits the practicality of full-thickness grafting to smaller wounds; moreover, graft failure is relatively common in equi...
Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? The goal in the therapeutic use of mesenchymal stem cells (MSCs) in musculoskeletal disease is to harness the regenerative nature of these cells focussing on their potential to grow new tissues and organs to replace damaged or diseased tissue. Laboratory isolation of MSCs is now well established and has recently been demonstrated for equine MSCs. Stem cell science has attracted considerable interest in both the scientific and clinical communities because of its potential to regenerate tissues. Research into the use of MSCs in tissue regeneration in general reflects human medical needs, however...
In vitro model of equine muscle regeneration. Equine satellite cells are responsible for muscle healing and regeneration in the mature horse. We describe the in vitro cell culture conditions required for clonal populations of equine satellite cells to undergo both proliferation and differentiation. Our hypothesis is that these in vitro conditions model regeneration of muscle and can be used to evaluate potential therapeutics. In this study, 2 areas of satellite cell response were tested: proliferation of clones induced by growth factors, and fusion induced by culture conditions. Equine satellite cell clones showed differences in their res...
Bone marrow response to large volume blood collection in the horse. Evaluation of erythropoietic regeneration in horses is difficult unless serial bone marrow aspirates are performed. To investigate the acute and chronic erythropoietic regenerative response of equine bone marrow following acute removal or loss of blood, sequential bone marrow aspirates over 4 weeks were taken from the sternum of five horses from which 20 ml kg(-1)of blood had been removed. We found that the total number of erythroid cells counted (expressed as a percentage of the total number of erythroid and myeloid cells counted) expanded initially by 13.7 per cent within 3 days after blood ...
